Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...

The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin ...

Automakers have long touted the benefits of fuel injection, claiming increased efficiency and power. But as more cars have the system installed (around 73% in 2023), more and more consumers are ...